Biochemical Pharmacology SCIE

国际简称：BIOCHEM PHARMACOL 参考译名：生化药理学

主要研究方向：医学-药学非预警期刊审稿周期：约1.0个月约3.3周

《生化药理学》(Biochemical Pharmacology)是一本由Elsevier Inc.出版的以医学-药学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

2区中科院分区
Q1 JCR分区
457 年发文量
5.3 IF影响因子
未开放 是否OA
181 H-index
1958 创刊年份
Semimonthly 出版周期
English 出版语言

Biochemical Pharmacology publishes original research findings, Commentaries and review articles related to the elucidation of cellular and tissue function(s) at the biochemical and molecular levels, the modification of cellular phenotype(s) by genetic, transcriptional/translational or drug/compound-induced modifications, as well as the pharmacodynamics and pharmacokinetics of xenobiotics and drugs, the latter including both small molecules and biologics.

The journal's target audience includes scientists engaged in the identification and study of the mechanisms of action of xenobiotics, biologics and drugs and in the drug discovery and development process.

All areas of cellular biology and cellular, tissue/organ and whole animal pharmacology fall within the scope of the journal. Drug classes covered include anti-infectives, anti-inflammatory agents, chemotherapeutics, cardiovascular, endocrinological, immunological, metabolic, neurological and psychiatric drugs, as well as research on drug metabolism and kinetics. While medicinal chemistry is a topic of complimentary interest, manuscripts in this area must contain sufficient biological data to characterize pharmacologically the compounds reported. Submissions describing work focused predominately on chemical synthesis and molecular modeling will not be considered for review.

While particular emphasis is placed on reporting the results of molecular and biochemical studies, research involving the use of tissue and animal models of human pathophysiology and toxicology is of interest to the extent that it helps define drug mechanisms of action, safety and efficacy.

[ 查看全部 ]

投稿咨询加急咨询

投稿热线：400-888-7501

Biochemical Pharmacology期刊信息

ISSN：0006-2952
出版语言：English
是否OA：未开放
E-ISSN：1873-2968
出版地区：UNITED STATES
是否预警：否
出版商：Elsevier Inc.
出版周期：Semimonthly
创刊时间：1958
开源占比：0.1174
Gold OA文章占比：20.83%
OA被引用占比：0.0641...
出版国人文章占比：0.16
出版撤稿占比：0
研究类文章占比：62.58%

Biochemical Pharmacology CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

10.3

1.365

1.106

学科类别	分区	排名	百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmacology	Q1	32 / 313	89%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Biochemistry	Q1	58 / 438	86%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Biochemical Pharmacology中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	PHARMACOLOGY & PHARMACY 药学	2区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	2区	PHARMACOLOGY & PHARMACY 药学	2区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	2区	PHARMACOLOGY & PHARMACY 药学	2区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	2区	PHARMACOLOGY & PHARMACY 药学	2区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	2区	PHARMACOLOGY & PHARMACY 药学	2区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	2区	PHARMACOLOGY & PHARMACY 药学	2区

Biochemical Pharmacology JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：PHARMACOLOGY & PHARMACY	SCIE	Q1	34 / 354	90.5%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：PHARMACOLOGY & PHARMACY	SCIE	Q1	32 / 354	91.1%

Biochemical Pharmacology历年数据统计

影响因子

中科院分区

Biochemical Pharmacology中国学者发文选摘

1、Sirtuin1-p53: A potential axis for cancer therapy
Author: Yin, Jia-yi; Lu, Xin-tong; Hou, Meng-ling; Cao, Ting; Tian, Zhen

Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 212, Issue , pp. -. DOI: 10.1016/j.bcp.2023.115543
2、Inhibition of STX17-SNAP29-VAMP8 complex formation by costunolide sensitizes ovarian cancer cells to cisplatin via the AMPK/mTOR signaling pathway
Author: Liang, Xiao; Yu, Chunlei; Tian, Yunhong; Xiang, Xiaocong; Luo, Yuexi

Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 212, Issue , pp. -. DOI: 10.1016/j.bcp.2023.115549
3、Activated AMPK mitigates diabetes-related cognitive dysfunction by inhibiting hippocampal ferroptosis
Author: Xie, Zheng; Wang, Xuan; Luo, Xiaoxiao; Yan, Jing; Zhang, Jie; Sun, Rao; Luo, Ailin; Li, Shiyong

Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115374
4、The role of Notch signaling pathway in metabolic bone diseases
Author: Gao, Yongguang; Fu, Zhanda; Guan, Junxia; Liu, Xinhua; Zhang, Qing

Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115377
5、Dipyridamole interacts with the N-terminal domain of HSP90 and antagonizes the function of the chaperone in multiple cancer cell lines
Author: Gao, Jing; Zhou, Chen; Zhong, Yan; Shi, Li; Luo, Xuanyang; Su, Haixia; Li, Minjun; Xu, Yechun; Zhang, Naixia; Zhou, Hu

Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115376
6、Upregulation of PIK3IP1 monitors the anti-cancer activity of PI3K alpha inhibitors in gastric cancer cells
Author: Ma, Xu-Bin; Wang, Yang; Jia, Ying-Jie; Liu, Ya-Jie; Tian, Ying-Qi; Liu, Ying; Hou, Gui-Qin; Xu, Yi-Chao; Liu, Hong-Min

Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115380
7、Exploring the potential molecular mechanism of trastuzumab-induced cardiotoxicity based on RNA sequencing and bioinformatics analysis
Author: Hou, Huan; Xu, Ying; Xie, Meilin; Chen, Rong

Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 208, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115388
8、Role of prostaglandin E2 in macrophage polarization: Insights into atherosclerosis
Author: Wang, Weixuan; Liang, Mingjie; Wang, Lexun; Bei, Weijian; Rong, Xianglu; Xu, Jianqin; Guo, Jiao

Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115357